Infectious Diseases (except HIV/AIDS)
Showing page 259 of 716 pages of list content
-
A generic method and software to estimate the transmission advantage of pathogen variants in real-time : SARS-CoV-2 as a case-study
This article's authors -
COVID-19 Clinical Characteristics and Outcomes in Children and Adolescents Hospitalized at the University Hospital of the West Indies, Jamaica in 2020-2021
This article's authors -
SARS-CoV-2 testing in the community: Testing positive samples with the TaqMan SARS-CoV-2 Mutation Panel to find variants in real-time
This article's authors -
SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates Against Symptomatic Infection
This article's authors -
Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial
This article's authors -
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
This article's authors -
Serological responses to COVID-19 booster vaccine in England
This article's authors -
Protective characteristics of COVID-19 convalescent and post-vaccination IgG antibodies
This article's authors -
HLA-A*03:01 is associated with increased risk of fever, chills, and more severe reaction to Pfizer-BioNTech COVID-19 vaccination
This article's authors -
Germany’s low SARS-CoV-2 seroprevalence confirms effective containment in 2020: Results of the nationwide RKI-SOEP study
This article's authors